TAMH
RMD icon

Taikang Asset Management (HK)’s ResMed RMD Stock Holding History

Taikang Asset Management (HK)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,798
Closed -$1.17M – 113
2024
Q3 		$1.17M Sell
4,798
-370
-7% -$82.7K 0.12% 95
2024
Q2 		$989K Sell
5,168
-11,949
-70% -$2.42M 0.15% 84
2024
Q1 		$3.39M Buy
17,117
+1,594
+10% +$292K 0.71% 39
2023
Q4 		$2.67M Buy
15,523
+1,687
+12% +$259K 0.51% 43
2023
Q3 		$16M Hold
13,836
– – 0.47% 48
2023
Q2 		$23.7M Sell
13,836
-13,836
-50% -$3.08M 0.7% 36
2023
Q1 		$47.6M Buy
27,672
+10,380
+60% +$2.25M 1.1% 34
2022
Q4 		$28.1M Sell
17,292
-22,732
-57% -$4.99M 0.76% 46
2022
Q3 		$68.6M Hold
40,024
– – 1.8% 19
2022
Q2 		$65.8M Sell
40,024
-286
-0.7% -$60.9K 1.62% 18
2022
Q1 		$9.78M Buy
40,310
+20,012
+99% +$4.84M 1.66% 16
2021
Q4 		$5.29M Hold
20,298
– – 1.05% 23
2021
Q3 		$5.35M Hold
20,298
– – 1.09% 18
2021
Q2 		$5M Hold
20,298
– – 0.77% 22
2021
Q1 		$3.94M Hold
20,298
– – 0.74% 31
2020
Q4 		$4.32M Buy
20,298
+2,812
+16% +$561K 0.64% 26
2020
Q3 		$3M Buy
17,486
+286
+2% +$52.8K 0.46% 43
2020
Q2 		$3.3M Buy
17,200
+171
+1% +$28K 0.59% 31
2020
Q1 		$2.51M Buy
17,029
+1,874
+12% +$298K 0.57% 28
2019
Q4 		$2.35M Hold
15,155
– – 0.59% 28
2019
Q3 		$2.05M Hold
15,155
– – 0.22% 33
2019
Q2 		$1.85M Hold
15,155
– – 0.21% 34
2019
Q1 		$1.58M Hold
15,155
– – 0.22% 38
2018
Q4 		$1.73M Buy
15,155
+2,118
+16% +$227K 0.3% 20
2018
Q3 		$1.5M Hold
13,037
– – 0.18% 34
2018
Q2 		$1.35M Buy
13,037
+3,267
+33% +$331K 0.15% 38
2018
Q1 		$962K Buy
9,770
+6,899
+240% +$652K 0.1% 36
2017
Q4 		$243K Buy
+2,871
New +$237K 0.03% 59

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Taikang Asset Management (HK)'s RMD Position: Q4 2024 in Review

Taikang Asset Management (HK) sold out of ResMed (RMD) in Q4 2024, closing a stake of 4,798 shares — an estimated $1.17M sold.

Taikang Asset Management (HK) first reported a position in RMD in Q4 2017 and held it in 28 quarters. The position peaked at $68.6M in Q3 2022. 872 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Taikang Asset Management (HK) reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • Taikang Asset Management (HK) sold 4,798 ResMed shares in Q4 2024, an estimated $1.17M.
  • Taikang Asset Management (HK) first reported a position in ResMed in Q4 2017 and held it in 28 quarters.
  • Taikang Asset Management (HK)'s ResMed position peaked at $68.6M in Q3 2022.
  • 872 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Taikang Asset Management (HK)'s 13F filing for Q4 2024, filed 11 Feb 2025.